iShares Exponential Technologies ETF (XT)
| Assets | $3.41B |
| Expense Ratio | 0.46% |
| PE Ratio | 27.17 |
| Shares Out | 52.00M |
| Dividend (ttm) | $0.44 |
| Dividend Yield | 0.67% |
| Ex-Dividend Date | Jun 16, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 18.10% |
| Volume | 121,202 |
| Open | 66.02 |
| Previous Close | 65.60 |
| Day's Range | 66.02 - 66.50 |
| 52-Week Low | 49.01 |
| 52-Week High | 66.50 |
| Beta | 1.08 |
| Holdings | 229 |
| Inception Date | Mar 19, 2015 |
About XT
Fund Home PageThe iShares Exponential Technologies ETF (XT) is an exchange-traded fund that mostly invests in information technology equity. The fund tracks an equal-weighted index that provides exposure to firms from developed and emerging markets, which create or use exponential technologies as defined by Morningstar. XT was launched on Mar 19, 2015 and is issued by BlackRock.
Top 10 Holdings
8.58% of assets| Name | Symbol | Weight |
|---|---|---|
| Innovent Biologics, Inc. | 1801 | 1.06% |
| Siemens Energy AG | ENR | 0.96% |
| Megaport Limited | MP1 | 0.91% |
| Palantir Technologies Inc. | PLTR | 0.88% |
| Nextracker Inc. | NXT | 0.88% |
| Cloudflare, Inc. | NET | 0.81% |
| SK hynix Inc. | 000660 | 0.81% |
| Zscaler, Inc. | ZS | 0.76% |
| BlackBerry Limited | BB | 0.76% |
| BridgeBio Pharma, Inc. | BBIO | 0.74% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 16, 2025 | $0.20895 | Jun 20, 2025 |
| Dec 30, 2024 | $0.00938 | Jan 3, 2025 |
| Dec 17, 2024 | $0.22385 | Dec 20, 2024 |
| Jun 11, 2024 | $0.15816 | Jun 17, 2024 |
| Dec 20, 2023 | $0.10657 | Dec 27, 2023 |
| Jun 7, 2023 | $0.14099 | Jun 13, 2023 |
Performance
XT had a total return of 13.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.76%.
News
XT: An Undervalued Portfolio Of Innovative Global Tech Stocks
iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investme...
XT: Still One Of My Top Ways To Take Equity Risk Going Forward
The iShares Exponential Technologies ETF is a great way for conservative investors to add higher-octane equity exposure to their portfolios. XT has exhibited relatively low downside risk compared to o...
XT Will Likely Continue Lagging The Broader IT Sector
iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversifi...
XT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot
iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversifie...
XT: Exponential Isn't Working
iShares Exponential Technologies ETF offers exposure to companies driving technological advances across various sectors globally. The XT ETF provides diversification with over 190 holdings, minimizing...
XT ETF: Performance History Leaves A Lot To Be Desired
XT invests in companies recognized as innovators, capitalizing on disruptive technologies. The rules-based strategy has lagged behind passively indexed equity benchmarks. We are bullish on stocks but ...
XT: Everyone Has To Chase AI
XT has a fair bit of AI exposure, through semiconductor and software companies, that has been driving its returns ahead of a typically weighted US index. We think that longer-term, the AI hype is over...
XT: I'll Take This ETF Over ARKK Any Time
XT and ARKK both seek to profit from investing in innovative companies. But they take different approaches to do that. ARKK is wildly popular and controversial. Cathie Wood, its founder, is a media st...
XT Should Be Leveraged To Good News Wednesday
XT is levered to a lot of healthcare stocks, skewed towards earlier stage, that are more equity market dependent. Otherwise there are a lot of tech companies that will be levered to bullish sentiment ...
XT: If You're Looking For An ARKK Alternative, Check This One Out
iShares Exponential Technologies ETF tracks the Morningstar Exponential Technologies Index. We like XT much better than the more-famous/infamous ARKK ETF, which we consider to be an XT peer. Exponenti...
XT: Nicely Diversified Exponential Tech Fund With Valuation, FX Risks
XT offers targeted exposure to the leading technology themes that are transforming the global economy, with a nicely diversified portfolio of 195 U.S. and international stocks in the current version. ...
XT: We're Going To Think Twice About This ETF
XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs.
XT: A More Defensive Disruptive Innovation Bet
XT is a less active alternative to ARK ETFs that also focuses on companies that benefit from technological innovation. XT's broadly diversified and balanced holdings, reasonable valuation metrics, and...
XT: Riding The Success Of Disruptive Technologies
Launched in March 2015, the iShares Exponential Technologies ETF invests globally in companies across nine technology themes. With a five-year performance history, the fund tracks an obscure index - t...
The hottest topics at the world's biggest ETF Conference
Ric Edelman of Edelman Financial and Tom Lydon of ETFTrends.com join 'ETF Edge' to sit with CNBC's Bob Pisani to discuss global growth fears, what ETFs you should invest in and the race to eliminate f...